Home

Epidemiology

Read time: 3 min

Survey reveals intriguing differences between Asian countries in antipsychotic prescribing, symptoms, and adverse event reporting

The Research on Asian Psychotropic Prescription Pattern (REAP) studies provide unique insights into...

Alzheimer's Disease

Read time: 5 min

Congress highlights

Making the most of Big Data in Alzheimer's Disease

In this symposium, recent trends in data analysis and study design were discussed alongside...

Alzheimer's Disease

Read time: 4 min

Unpicking Alzheimer disease and depression

In this symposium four speakers discussed different approaches to investigating the intersection...

Read time: 4 min

Accentuate the negative: drawing attention to negative symptoms in schizophrenia

Impaired learning from experiences that bring reward and overestimating the effort needed to reach...

Read time: 3 min

Disclosure can create a virtuous circle as solidarity replaces stigma

Being open about mental illness is positive both for society and for the individual concerned,...

Bipolar, Schizophrenia

Read time: 4 min

Family history: great risk requires great help with resilience

Children at-risk of schizophrenia due to family history are often almost invisible to social and...

Bipolar, Schizophrenia

Read time: 4 min

Dopamine synthesis is the common factor in genetic and environmental risks in schizophrenia

Excessive striatal dopamine synthesis was the common thread that Robin Murray (Institute of...

Read time: 4 min

Congress highlights

Mortality excess in schizophrenia: can we close the gap?

People with first-episode psychosis who had no antipsychotic medication treatment had a five-year...

Alzheimer's Disease

Read time: 4 min

The promise of person-centered care

Postponing the need for admission to an institution, and improving quality of life within it...

Alzheimer's Disease

Read time: 4 min

β-amyloid remains a compelling target

Neuropathology, genetics and biology all support the idea that β-amyloid is central to the...

Alzheimer's Disease

Read time: 4 min

Biomarkers in trials and practice

The correlation between cerebrospinal fluid (CSF) and Positron Emission Tomography (PET) biomarkers...

Read time: 2 min

Value of Treatment: European Brain Council publishes landmark report

Greater clinical benefit for patients and gains in cost-effectiveness for society -- both can be...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country